©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Transforming Growth Factor-1 Inhibits Nucleosomal Fragmentation in Human Keratinocytes following Loss of Adhesion (*)

(Received for publication, September 14, 1995; and in revised form, October 25, 1995)

Kris F. Sachsenmeier Nader Sheibani Sandra J. Schlosser B. Lynn Allen-Hoffmann (§)

From the Department of Pathology and the Environmental Toxicology Center, Madison, Wisconsin 53706

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

We have investigated the role of transforming growth factor-beta1 (TGF-beta1) in suspension-induced programmed cell death of cultured human keratinocytes. Suspension of keratinocytes in semisolid medium induces TGF-beta1 mRNA levels and synthesis of bioactive TGF-beta1 protein. Concomitant with the suspension-induced increase in secreted TGF-beta1 levels, steady state mRNA levels for c-myc are decreased. Both exogenously added and endogenously produced TGF-beta1 attenuate suspension-induced nucleosomal fragmentation in keratinocytes. We propose that TGF-beta1 may function to protect keratinocytes from DNA fragmentation following loss of cell-substratum and/or cell-cell contact. Taken together, our findings suggest that loss of cell-substratum and/or cell-cell adhesion is an important component of an apoptotic signal transduction cascade regulated by TGF-beta1 in normal human stratified squamous epithelia.


INTRODUCTION

We have described the morphological and biochemical features of apoptosis in cultured normal human keratinocytes and identified loss of cell-cell and/or cell-substratum contact as an important signal for keratinocyte cell death in vitro. (^1)The pleiotropic molecule transforming growth factor beta1 (TGF-beta1) (^2)has been shown to be a potent modulator of the apoptotic process in a variety of cell types. In certain simple epithelial cell types and hematopoietic cells, TGF-beta1 has been reported to induce programmed cell death (Oberhammer et al., 1992; Rotello et al., 1991; Lotem and Sachs, 1992). TGF-beta1 also inhibits the growth of normal human keratinocytes in vitro (Pietenpol et al., 1990). Based on studies using normal human keratinocytes and the murine keratinocyte cell line, BALB/MK, it is known that TGF-beta1 inhibits keratinocytes in the G(1) phase of the cell cycle (Shipley et al., 1986) through a mechanism that most likely involves transcriptional down-regulation of c-myc expression (Pietenpol et al., 1990; Munger et al., 1992). In the present study, we identify TGF-beta1 as an important inhibitor of apoptosis in cultured normal human keratinocytes. We propose that TGF-beta1 may function as a signal to forestall apoptosis as well as replication in the basal layer of human skin.


MATERIALS AND METHODS

Cell Culture

Normal keratinocytes were isolated from newborn human foreskin. Keratinocyte cultures were established by plating aliquots of the single cell suspension in the presence of mitomycin C-treated 3T3 feeder cells as described by Allen-Hoffmann and Rheinwald(1984). The standard keratinocyte culture medium was composed of a mixture of Ham's F12/Dulbecco's modified Eagle's medium (DMEM) (3:1, 0.66 mM calcium) supplemented with 2.5% fetal calf serum, 0.4 µg/ml hydrocortisone, 8.4 ng/ml cholera toxin, 5 µg/ml insulin, 24 µg/ml adenine, 10 ng/ml EGF, 100 units of penicillin, and 100 µg/ml streptomycin. Twenty-four hours prior to treatment, 3T3 feeder cells were removed from keratinocyte cultures by 0.5 mM EDTA rinses, and standard keratinocyte growth medium was replaced. Normal keratinocytes were not used beyond passage 5. NRK cells, clone 49F (American Type Tissue Collection, CRL 1570), were cultured in Dulbecco's modified Eagle's medium supplemented with 10% calf serum. Experiments were performed with NRK cells before passage 25. All cultures were maintained at 37 °C in a 5% CO(2) atmosphere.

Cell Treatments

For suspension studies, adherent cells were suspended in semisolid medium or treated with medium alone for the indicated times. Medium was made semisolid with sterile methylcellulose (4,000 centipoises, Fisher Scientific) as described previously (Sadek and Allen-Hoffmann, 1994). Unless otherwise indicated, semisolid media were composed of serum-free Ham's F12/DMEM (3:1) containing 1.68% methylcellulose and supplemented with the aforementioned additives.

Cells were suspended following removal from tissue culture plates with 0.5 mM EDTA, 0.1% trypsin, washed with serum-containing medium to inactivate residual trypsin, then with serum-free medium, and suspended in the desired semisolid medium at a density of 1 times 10^6 cells/ml in sterile 50-ml polypropylene tubes. Suspended cells were incubated at 37 °C in a humidified 5% CO(2) atmosphere. Cells were recovered from suspension at various times by repeated dilution of the semisolid medium with serum-free medium followed by centrifugation at 440 times g. Adherent control cultures were treated with medium alone for the indicated times.

Measurement of Internucleosomal Fragmentation

Following treatments, 2.5 times 10^6 cells were lysed in 500 µl of 50 mM Tris, 10 mM EDTA, pH 8.0, and 0.5% (w/v) sodium lauroyl sarcosine, and the lysate was aliquoted and stored at -85 °C. Following addition of 500 µl of 10 mM Tris, 1 mM EDTA, pH 8.0 (TE buffer) the lysate was extracted twice in a siliconized microcentrifuge tube with an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1, v/v/v), treated with DNase-free RNase A (Sigma), 50 µg/ml final concentration, for 15 min at 37 °C, and extracted again with an equal volume phenol:chloroform:isoamyl alcohol. The aqueous phase was extracted twice with an equal volume of chloroform alone, and nucleic acids were precipitated overnight at -85 °C following addition of 0.1 volume of 3 M sodium acetate, pH 5.2, and 2 volumes of ice-cold absolute ethanol. DNA was collected by centrifugation at 16,000 times g in a Microfuge (Beckman Instruments) for 30 min. The DNA was rinsed with 95% ethanol, air-dried for 5 min, and dried in a HetoVac CS1 vacuum concentrator (InterMed, Denmark) for 5 min. The DNA was dissolved in 20 µl of TE buffer, pH 8.0. DNA was quantitated by absorption at 260 nm and stored at 4 °C at a concentration of 0.5 mg/ml in TE.

Intact and fragmented DNA was 3`-end-labeled with [alpha-P]ddATP using terminal dideoxynucleotidylexotransferase as described by Tilly and Hsueh (1993). Briefly, each reaction mixture contained 1 times reaction buffer (0.2 M potassium cacodylate, 25 mM Tris-HCl, 0.25 mg/ml bovine serum albumin, pH 6.6), 2.5 mM CoCl(2), 25 units of terminal dideoxynucleotidyltransferase (Boehringer Mannheim), and [alpha-P]ddATP (specific activity of 3000 Ci/mmol, Amersham Corp.) diluted with cold ddATP to a final concentration of 340 pM ddATP or 12.5 µCi/reaction. Each reaction was initiated by the addition of 360 ng of sample DNA, incubated for 60 min at 37 °C, and terminated by the addition of 25 mM EDTA, pH 8.0, final concentration. Labeled DNA was separated from unincorporated [alpha-P]ddATP by precipitation with ice-cold 100% ethanol in the presence of 2 M ammonium acetate and 50 µg of yeast tRNA (Sigma) followed by a second precipitation with ice-cold 100% ethanol. The pellet was collected by centrifugation, rinsed in ice-cold 80% ethanol, dissolved in 50 µl of TE buffer, pH 8.0, and stored at -20 °C. One half of each labeled sample was loaded onto a 1.5% agarose gel and electrophoresed. Gels were dried without heat using a vacuum dryer (Bio-Rad) or with heat using a SE 1200 Easy Breeze (Hoeffer Scientific, San Francisco, CA) and exposed to X-Omat photographic film.

Northern Analysis

Poly(A) RNA was isolated from logarithmically growing cells as described previously (Sadek and Allen-Hoffmann, 1994). Poly(A) RNA was electrophoresed in a 1.2% agarose gel containing formaldehyde and electroblotted to a Zeta-probe membrane (Bio-Rad). The membrane was prehybridized and then hybridized in the presence of a random primer [P]dCTP-labeled cDNA probe as recommended by the supplier. The cDNA probes used were to rat glyceraldehyde-3-phosphate dehydrogenase, pGPDN5 (Fort et al., 1985), monkey TGF-beta1 (Sharples et al., 1987), and a 830-base pair 5`-fragment of human c-myc (Miyamoto et al., 1985).

Anchorage-independent Growth Assay

Anchorage-independent growth of NRK-49F cells in keratinocyte-conditioned semisolid medium was determined by a methylcellulose/agar assay. Conditioned semisolid medium was generated by the suspension of subconfluent cultures of keratinocytes in serum-free Ham's F12/DMEM (3:1) supplemented with 1.68% methylcellulose and antibiotics for the indicated times. Keratinocytes were removed from semisolid medium by centrifugation at 27,000 times g for 20 min at 4 °C. To assay anchorage-independent growth, a 0.5-ml aliquot of semisolid medium supplemented with 10% calf serum, 10 ng/ml EGF, and NRK-49F indicator cells (6 times 10^3 cells/ml) was layered over 0.5 ml of the bottom layer of 0.5% Noble agar in DMEM supplemented with 10% calf serum, 100 units/ml penicillin, and 100 µg/ml streptomycin in a CoStar 24-well plate. A standard curve for TGF-beta1-dependent anchorage-independent NRK-49F cell growth was generated for each experiment using the following concentrations of recombinant TGF-beta1: 0.05, 0.1, 0.5, 1.0, and 2.0 ng/ml semisolid medium. In some experiments, the conditioned and unconditioned methylcellulose-containing medium was supplemented with 2.5 µg/ml turkey anti-human TGF-beta1 neutralizing antibody (Collaborative Biomedical Products, Bedford, MA) for 1 h at room temperature prior to the addition of NRK-49F cells. After 7 days, colonies geq60 µm were scored.


RESULTS

Suspension of Keratinocytes Induces TGF-beta1 Expression

In certain simple epithelial cell types and hematopoietic cells, TGF-beta1 has been reported to induce programmed cell death (Oberhammer et al., 1992; Rotello et al., 1991; Lotem and Sachs, 1992). Because suspension is a potent inducer of apoptosis in normal human keratinocytes, we asked if suspension affected the level of autocrine production of keratinocyte TGF-beta1. Poly(A) RNA was isolated from adherent keratinocytes and cells suspended in serum-free semisolid medium for 6, 12, 24, and 72 h. Two keratinocyte strains from different donors were analyzed. In both strains suspension caused an increase in the steady state levels of TGF-beta1 mRNA within 6 h (Fig. 1). Concomitant with the increase in keratinocyte TGF-beta1 mRNA levels, steady state c-myc RNA levels decline in a time-dependent manner. This finding is consistent with the known effects of TGF-beta1 on c-myc gene expression in keratinocytes. These results suggest that suspension increases the amount of TGF-beta1 protein produced by keratinocytes.


Figure 1: Suspension increases steady state TGF-beta1 mRNA levels in cultured normal human keratinocytes. Adherent keratinocytes (0 h), strains SK-2-Ep and NS-2-Ep, were suspended for 6, 12, 24, and 72 h in serum-free, semisolid growth medium without EGF. Poly(A) RNA was prepared from each time point, and 3 µg of RNA was loaded per lane. Northern analysis was performed using random primer-labeled [P]cDNA probes for TGF-beta1 and c-myc. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was used as a loading control. Kb, kilobases.



We next determined if suspended keratinocytes produced increased levels of biologically active TGF-beta1. Keratinocytes were suspended in serum-free and additive-free semisolid medium for 0, 12, 24, and 48 h. Following suspension, keratinocytes were removed by centrifugation to generate keratinocyte-conditioned semisolid medium. To control for lysis of keratinocytes following centrifugation, keratinocytes were suspended in semisolid medium and immediately removed (t = 0). Anchorage-independent growth of NRK-49F cells was used as a bioassay to determine the presence of biologically active TGF-beta1 in keratinocyte-conditioned medium. Neutralizing anti-TGF-beta1 antibody was added to the keratinocyte-conditioned medium to confirm that TGF-beta1 alone was inducing anchorage-independent growth. As seen in Fig. 2, keratinocyte-conditioned medium supports the anchorage-independent growth of the NRK-49F indicator cells. Surprisingly, non-acidified keratinocyte-conditioned medium supported NRK-49F colony formation as well as acidified medium (data not shown). These results demonstrate that the number of anchorage-independent colonies is proportional to the amount of time the keratinocytes conditioned the semisolid medium. Suspended keratinocytes typically produced the equivalent of between 50 and 100 pg of recombinant human TGF-beta1/ml of semisolid medium. Inhibition of TGF-beta1 with neutralizing anti-TGF-beta1 antibody decreased NRK-49F colony formation to background levels. Twice as much antibody was required to neutralize the activity in 48-h keratinocyte-conditioned medium. Therefore, loss of keratinocyte cell-cell and/or cell-substratum interaction is an inducer of TGF-beta1 gene expression and ultimately promotes increased synthesis and perhaps activation of this epithelial growth inhibitor.


Figure 2: Conditioned medium from suspended keratinocytes contains active TGF-beta1. Cultured keratinocytes were suspended in serum-free, additive-free, semisolid growth medium for 12, 24, and 48 h to generate conditioned semisolid medium (CM). Keratinocytes were removed from the conditioned medium by centrifugation without dilution of the semisolid medium. To control for possible cell lysis during centrifugation, keratinocytes were suspended in semisolid medium and immediately removed by centrifugation (0 h conditioned semisolid medium). Indicator cells, NRK-49F, were assayed for anchorage-independent growth in the keratinocyte-conditioned media. Conditioned medium was incubated with or without a neutralizing anti-human TGF-beta1 antibody (2.5 µg/ml) for 1 h prior to the addition of NRK-49F cells. As a control for background levels of anchorage-independent growth, NRK-49F cells were suspended in semisolid medium supplemented with EGF alone. A standard curve for TGF-beta1-dependent anchorage-independent NRK-49F cell growth was generated for each experiment using the following concentrations of recombinant TGF-beta1: 0.05, 0.1, 0.5, 1.0, and 2.0 ng/ml semisolid medium. After 7 days, anchorage-independent colonies of NRK-49F cells were scored. Data represent the average number (mean ± S.D. of three replicates per condition) of colonies (>60 µm) per well.



TGF-beta1 Attenuates Suspension-induced DNA Fragmentation

To investigate a possible causal relationship between TGF-beta1 and apoptosis in human keratinocytes, we treated adherent and suspended keratinocytes with 5 ng/ml TGF-beta1 in serum-free medium for 24 h. Following treatment the cells were analyzed for nucleosomal fragmentation and the ability to initiate a colony when replated in surface culture. In adherent keratinocytes, treatment with TGF-beta1 for 24 h did not alter the colony-forming ability upon replating when compared with control (Fig. 3A) or induce DNA fragmentation (Fig. 3B, compare lanes 1 and 2). Surprisingly, treatment of suspended keratinocytes with TGF-beta1 attenuated suspension-induced DNA fragmentation (Fig. 3B, compare lanes 3 and 4). Furthermore, addition of TGF-beta1 to the semisolid medium modestly enhanced the colony-forming potential of suspended keratinocytes. We next determined if endogenous TGF-beta1 from suspended keratinocytes affected DNA fragmentation. To inhibit the effects of suspension-mediated endogenous TGF-beta1, we suspended keratinocytes in semisolid medium containing a TGF-beta1 neutralizing antibody. Neutralization of keratinocyte TGF-beta1 consistently increased DNA fragmentation following suspension (Fig. 4), although the magnitude of this response varies among experiments. Therefore, in normal human keratinocytes, TGF-beta1 appears to attenuate nucleosomal fragmentation following abrogation of cell-substratum and/or cell-cell interactions.


Figure 3: TGF-beta1 inhibits internucleosomal cleavage in suspended keratinocytes. Keratinocytes (NS-2-Ep) were suspended for 24 h in serum-free, semisolid growth medium containing 5 ng/ml TGF-beta1 or an equal volume of diluent (4 mM HCl, 1 mg/ml bovine serum albumin). Adherent control cells were refed with serum-free growth medium containing 5 ng/ml TGF-beta1 or diluent at the beginning of the treatment period. A, keratinocytes were plated onto mitomycin C-treated 3T3 feeder layers to determine the effect of treatments on replicative potential in surface culture. After 14 days, cultures were fixed with formaldehyde, stained with methylene blue, and counted. Data represent the average colony-forming efficiency (CFE, mean ± S.D. of six replicates per treatment) for each condition. B, following treatment, genomic DNA was isolated, labeled on 3`-ends with [alpha-P]ddATP, displayed on a 1.5% agarose gel, and subjected to autoradiography.




Figure 4: Neutralization of keratinocyte-derived TGF-beta1 promotes internucleosomal cleavage in suspended keratinocytes. Keratinocytes (NS-2-Ep) were suspended for 24 h in serum-free semisolid growth medium in the presence or absence of a neutralizing antibody (Ab) to human TGF-beta1. Adherent control cells received serum-free growth medium with or without anti-TGF-beta1 antibody at the beginning of the 24-h treatment period. Following treatments, genomic DNA was isolated, labeled on 3`-ends with [alpha-P]ddATP, displayed on a 1.5% agarose gel, and subjected to autoradiography.




DISCUSSION

We found that suspended keratinocytes contained increased levels of both TGF-beta1 mRNA and activated protein. TGF-beta1 is an autocrine growth factor that inhibits the growth of adherent human keratinocytes in vitro (Shipley et al., 1986; Pietenpol et al., 1990). Suspension of keratinocytes also results in a decrease in the steady state mRNA levels of c-myc. This finding is consistent with the known effects of suspension and TGF-beta1 on the growth of keratinocytes. We suspect that the suspension-induced decrease in c-myc mRNA levels may be mediated, in part, through increased production of TGF-beta1. The role of TGF-beta1 in terminal differentiation or programmed cell death in stratified squamous epithelia is unclear. In vivo, TGF-beta1 plays a role in the maintenance of normal tissue architecture in rodent skin. For example, transgenic mice homozygous for a targeted disruption of the TGF-beta1 locus exhibit epidermal hyperproliferation as measured by an increase in the labeling index of basal cell nuclei following administration of 5-bromo-2`-deoxyuridine (Glick et al., 1993). However, these TGF-beta1 null mice express the differentiation-specific keratins, K1 and K10, normally (Glick et al., 1993). Based on these reports and our findings it is reasonable to postulate that TGF-beta1 may exert its effect on epidermal homeostasis by affecting the number of cells present in the tissue as opposed to directly affecting the synthesis and/or organization of differentiation-specific proteins.

We have recently found that suspension of normal human keratinocytes induces both morphological and biochemical features of programmed cell death, such as membrane blebbing and DNA fragmentation.^1 Because TGF-beta1 has been implicated in the regulation of programmed cell death in a variety of epithelial cell types (Rotello et al., 1991; Oberhammer et al., 1991; Bursch et al., 1993), we determined if endogenous production of TGF-beta1 played a role in suspension-mediated apoptotic signaling in keratinocytes. In contrast to findings in hepatocytes and hematopoietic and lymphoid cells, we found that TGF-beta1 protected against suspension-induced DNA fragmentation in keratinocytes. Treatment of suspended keratinocytes with exogenously added TGF-beta1 dramatically attenuated suspension-induced nucleosomal fragmentation. Furthermore, neutralizing endogenously produced TGF-beta1 activity in suspended keratinocytes increased DNA fragmentation. Neither DNA fragmentation nor colony-forming efficiency was affected by treatment of adherent cells with TGF-beta1. It is possible that TGF-beta1 delays the onset of suspension-induced DNA fragmentation rather than blocking the apoptotic response altogether. Nevertheless, it is clear that TGF-beta1 does not promote apoptosis in adherent or suspended human keratinocytes in vitro. Based on these findings, we propose that TGF-beta1 functions to protect cultured keratinocytes from suspension-induced DNA fragmentation. Consistent with this interpretation, TGF-beta1 is present exclusively in the basal layer of normal mouse epidermis (Glick et al., 1993) where it may serve to protect against apoptosis in the replicative compartment of skin. TGF-beta1 also increases expression of cell adhesion molecules such as fibronectin, collagens, and their cognate cell surface receptors (reviewed by Massague(1990)), thereby potentially increasing cellular adhesiveness. Our findings may have important implications for the current understanding of normal epidermal wound healing (reviewed by Gailit and Clark(1994)). For example, increased endogenous levels of TGF-beta1, as well as that contributed by platelets, may serve to forestall injury-induced apoptosis in a wound while increasing the production of extracellular matrix and keratinocyte adhesiveness. TGF-beta1, although a potent keratinocyte growth inhibitor, may serve to forestall apoptosis in this renewal tissue during times of tissue regeneration.


FOOTNOTES

*
These studies were supported in part by National Institutes of Health Grant AR40284 (to B. L. A.-H.), National Institute of Environmental Health Science Traineeship T32 ES07015 (to K. F. S.), and Predoctoral Individual National Research Service Award F31 AR08366 (to K. F. S.). This is contribution 276 from the Environmental Toxicology Center, University of Wisconsin. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Dept. of Pathology and the Environmental Toxicology Center, 5638 Medical Sciences Center, Madison, WI 53706. Tel.: 608-262-2884; Fax: 608-265-3301; blallenh@facstaff.wisc.edu.

(^1)
K. F. Sachsenmeier and B. L. Allen-Hoffmann, submitted for publication.

(^2)
The abbreviations used are: TGF-beta1, transforming growth factor beta1; DMEM, Dulbecco's modified Eagle's medium; EGF, epidermal growth factor; NRK, normal rat kidney; ddATP, dideoxy-ATP.


ACKNOWLEDGEMENTS

We are grateful to Michelle Hines, Christine Sadek, and Margaret Weitzel for critically reading the manuscript.


REFERENCES

  1. Allen-Hoffmann, B. L., and Rheinwald, J. G. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 7802-7806 [Abstract]
  2. Bursch, W., Oberhammer, F., Jirtle, R. L., Askari, M., Sedivy, R., Grasl-Kraupp, B., Purchio, A. F., and Schulte-Hermann, R. (1993) Br. J. Cancer 67, 531-536 [Medline] [Order article via Infotrieve]
  3. Fort, P., Marty, L., Piechaczyk, M., El Sabrouty, S., Dani, C., Jeanteur, P., and Blanchard, J. M. (1985) Nucleic Acids Res. 13, 1431-1442 [Abstract]
  4. Gailit, J., and Clark, R. A. F. (1994) Curr. Opin. Cell Biol. 6, 717-725 [Medline] [Order article via Infotrieve]
  5. Glick, A. B., Kulkarni, A. B., Tennenbaum, T., Hennings, H., Flanders, K. C., O'Reilly, M., Sporn, M. B., Karlsson, S., and Yuspa, S. H. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 6076-6080 [Abstract]
  6. Lotem, J., and Sachs, L. (1992) Blood 80, 1750-1757 [Abstract]
  7. Massague, J. (1990) Annu. Rev. Cell Biol. 6, 597-641 [CrossRef]
  8. Miyamoto, C., Chizzonite, R., Crowl, R., Ruppecht, K., Kramer, R., Schaber, M., Kumar, G., Poonian, M., and Ju, G. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 7232-7236 [Abstract]
  9. Munger, K., Pietenpol, J. A., Pittelkow, M. R., Holt, J. T., and Moses, H. L. (1992) Cell Growth & Differ. 3, 291-298
  10. Oberhammer, F. A., Bursch, W., Parzefall, W., Breit, P., Erber, E., Stadler, M., and Schulte-Hermann, R. (1991) Cancer Res. 51, 2478-2485 [Abstract]
  11. Oberhammer, F. A., Pavelka, M., Sharma, S., Riefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5408-5412 [Abstract]
  12. Pietenpol, J. A., Holt, J. T., Stein, R. W., and Moses, H. L. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 3758-3762 [Abstract]
  13. Rotello, R. J., Lieberman, R. C., Purchio, A. F., and Gerschenson, L. E. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 3412-3415 [Abstract]
  14. Sadek, C. M., and Allen-Hoffmann, B. L. (1994) J. Biol. Chem. 269, 16067-16074 [Abstract/Free Full Text]
  15. Sharples, K., Plowman, G. D., Rose, T. M., Twardzik, D. R., and Purchio, A. F. (1987) DNA (N. Y.) 6, 239-244
  16. Shipley, G. D., Pittelkow, M. R., Wille, J. J., Jr., Scott, R. E., and Moses, H. L. (1986) Cancer Res. 46, 2068-2071 [Abstract]
  17. Tilly, J. L., and Hsueh, A. J. (1993) J. Cell. Physiol. 154, 519-526 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.